Liquid-format product provides 0.7 mcg of chromium and a 200 mg proprietary blend containing botanical extracts, amino acids and related ingredients; company publishes serving, safety and research-context information alongside the U.S. launch
LAKELAND, Fla., September 29, 2026 — Olivaro Drops has announced the availability of a 30 mL liquid dietary supplement that contains 0.7 mcg of chromium per serving, which is intended to support blood sugar levels. The proprietary blend contains undisclosed amounts of various ingredients, which complicates the assessment of its effectiveness for blood sugar management.
Olivaro’s current product information places those ingredients within one combined proprietary blend rather than assigning an individual amount to each component. That distinction is important when comparing the product with published ingredient research because studies conducted with separately measured quantities cannot establish the effects of a finished formula whose individual blend quantities are not disclosed.
“The purpose of publishing the full label information with the launch is to document the formulation, serving directions and safety information as clearly as possible,” said Kevin Moore, Product Head at Instituto Experience. “Research involving individual ingredients should remain tied to the doses and preparations actually studied rather than being presented as evidence for the complete Olivaro formulation.”
Current Olivaro Formula and Serving Information
Olivaro is supplied as a 30 mL, or 1 fluid ounce, Olivaro liquid dietary supplement. The Supplement Facts panel lists one milliliter as a serving and identifies 30 servings per container.
The label’s suggested-use instructions state that the bottle should be shaken before each use and that consumers may take one or two droppers full daily, placing the liquid in the mouth and swallowing. Consumers should rely on the physical label supplied with the product for current directions and should not exceed the recommended amount.
Chromium is the only dietary ingredient listed outside the proprietary blend with an individually disclosed quantity. The panel identifies 0.7 mcg of chromium as chromium picolinate per 1 mL serving.
The proprietary blend includes various ingredients, but the lack of individual ingredient amounts makes it difficult to assess its effectiveness for blood sugar management. Because the 200 mg figure applies to the blend as a whole, the Supplement Facts panel does not establish how many milligrams of maca, Gymnema, green tea, L-arginine, ginseng or another individual component are present.
That limitation affects how outside scientific literature can be interpreted in relation to the product.
Why Olivaro Is Publishing Formula and Research Context
Multi-ingredient dietary supplements are often discussed by referring to research involving one ingredient at a time. A clinical study, however, normally specifies the exact ingredient or standardized extract used, its amount, treatment duration, participant population and the measurements researchers evaluated.
Those details matter when comparing a published study with a commercial formula.
A study using hundreds of micrograms of chromium cannot automatically establish an outcome for a product containing 0.7 mcg. Similarly, a study involving a measured quantity of a botanical extract cannot establish what that ingredient contributes when its individual quantity inside a 200 mg multi-component blend is not disclosed.
The Olivaro information therefore separates three questions: what the current product label contains, what researchers have found when particular ingredients were studied independently, and what has actually been demonstrated for the complete Olivaro formulation.
The first two questions can provide useful background. They do not, by themselves, answer the third.
Chromium: Current Label Amount Differs Substantially From Research Doses
Olivaro lists 0.7 mcg of chromium as chromium picolinate per 1 mL serving.
Chromium is a trace element naturally present in some foods and available in dietary supplements. The National Institutes of Health Office of Dietary Supplements notes that chromium is sold in several supplemental forms, including chromium picolinate.
The NIH also reports that chromium supplements commonly contain amounts in the tens or hundreds of micrograms. Chromium-only supplements frequently provide approximately 200 to 500 mcg, while clinical trials investigating glucose-related outcomes have often used amounts ranging from hundreds of micrograms to approximately 1,000 mcg per day.
Those quantities are substantially different from the 0.7 mcg listed in one Olivaro serving.
Research concerning chromium and glucose metabolism has also produced inconsistent findings. NIH reviews note that some studies have reported changes in certain glucose-related measurements, while others have found no significant differences, leaving the clinical significance uncertain.
The National Center for Complementary and Integrative Health similarly states that studies of chromium and other dietary supplements for diabetes have produced mixed findings and that the evidence does not support using supplements as replacements for established medical treatment.
Olivaro’s 0.7 mcg chromium quantity should therefore be treated as a label specification, not as evidence that the product reproduces findings from trials using substantially larger amounts.
Proprietary Blend Contains 22 Components Within 200 mg
The largest portion of the Olivaro Supplement Facts panel is its 200 mg proprietary blend.
The botanical portion begins with maca (Lepidium meyenii) root extract, grape (Vitis vinifera) seed extract, guarana (Paullinia cupana) seed extract and African mango (Irvingia gabonensis) seed extract.
The label also identifies Eleutherococcus senticosus root extract, astragalus root extract, green tea (Camellia sinensis) leaf extract, Gymnema leaf extract, Coleus forskohlii root extract, Capsicum annuum fruit extract, grapefruit (Citrus paradisi) fruit extract and Panax ginseng aerial extract.
Raspberry ketones and a series of amino acids and related compounds complete the blend.
Because all of these ingredients share the same 200 mg total, the label does not provide enough information to determine whether any one ingredient appears at a quantity comparable with a clinical study.
That prevents responsible product-level conclusions from being drawn simply from the presence of an ingredient name.
Green Tea and Guarana Require Dose Context
Olivaro’s proprietary blend lists both green tea leaf extract and guarana seed extract.
Green tea has been investigated in numerous nutritional studies, but research differs according to whether participants consumed brewed tea, concentrated extracts or specifically standardized preparations. The National Center for Complementary and Integrative Health also notes that green tea naturally contains caffeine and that concentrated green tea supplements can have different safety considerations from the beverage.
The Olivaro Supplement Facts panel does not disclose an individual green tea amount or a separate caffeine quantity.
The presence of green tea and guarana on the label should therefore not be interpreted as establishing a specific caffeine dose or stimulant effect. The formulation would need a separately disclosed caffeine amount or appropriate analytical information before a precise caffeine quantity could be stated.
Consumers who are sensitive to caffeine or who obtain caffeine from coffee, tea, energy products or other supplements should review the complete physical label and seek additional information when necessary.
Panax Ginseng Research Is Not Evidence for the Complete Formula
Panax ginseng aerial extract also appears within the proprietary blend.
The National Center for Complementary and Integrative Health reports that Asian ginseng has been evaluated in many small clinical trials covering a wide range of outcomes. For glucose-related measures specifically, the research remains conflicting and does not support simple conclusions that can be applied across products.
The research also commonly involves defined extracts and quantities.
Olivaro does not disclose the individual amount of Panax ginseng contained within its 200 mg blend. Research involving a separately dosed ginseng preparation therefore cannot establish what the ingredient contributes to Olivaro.
NCCIH also notes that Asian ginseng may interact with certain medications and that people taking medicines should discuss herbal-product use with an appropriate healthcare professional.
Grapefruit Extract Creates an Additional Label Consideration
The Olivaro blend lists grapefruit fruit extract.
The U.S. Food and Drug Administration has documented that grapefruit and grapefruit juice can interact with certain prescription and over-the-counter medications by affecting drug-metabolizing enzymes or transport proteins. The nature and strength of an interaction vary depending on the medication and the amount of grapefruit consumed.
The presence of grapefruit extract in Olivaro does not establish that the product will produce the same interaction observed with grapefruit juice. The quantity of grapefruit extract is not individually disclosed, and the chemical composition of an extract can differ from that of a food or beverage.
The ingredient is nevertheless relevant to consumers using medications known to carry grapefruit warnings.
People taking prescription medication should review their medication information and consult a pharmacist or healthcare professional if they are uncertain about combining a grapefruit-containing supplement with their treatment.
Amino Acids Are Present Without Individual Quantities
Olivaro also lists several amino acids within its proprietary blend.
The label includes L-glutamine, L-tyrosine, L-arginine base, beta-alanine, L-ornithine HCl, L-tryptophan and L-carnitine base. GABA, or gamma-aminobutyric acid, and monoammonium glycyrrhizinate are also listed.
Research involving these ingredients frequently uses individually measured quantities, often expressed in hundreds of milligrams or grams.
Because the combined Olivaro blend totals only 200 mg across 22 ingredients, published studies using separately administered quantities cannot automatically be applied to the finished formula.
The current label establishes the presence of these ingredients but does not establish a research-equivalent dose for any one of them.
What Current Research Does and Does Not Establish
Olivaro’s current formula brings together chromium, botanical extracts, amino acids and related components in one liquid dietary supplement.
Published scientific research can provide background about some of those individual ingredients. It can explain their composition, document how they have been investigated and identify areas where results are conflicting or incomplete.
That research does not establish that the complete Olivaro formula produces the same outcomes.
No source identified for this announcement establishes that the complete 22-component proprietary blend plus chromium has been evaluated in a randomized controlled clinical trial.
Accordingly, Olivaro should not be described as clinically proven to lower blood glucose, reverse insulin resistance, prevent diabetes, replace medication or treat another medical condition.
NCCIH specifically cautions that dietary supplements should not be substituted for established diabetes treatment and notes that evidence for supplements marketed around blood glucose remains insufficient for broad conclusions.
Front-Label Language and Regulatory Context
The Olivaro package uses the wording “Balanced Blood Sugar Advanced Support” and “Fasting Blood Sugar Health Support.”
Those phrases describe the positioning printed on the product label. They should not be converted into claims that the finished product has been demonstrated to lower fasting glucose, treat diabetes or produce another specific clinical result.
FDA distinguishes dietary supplements from drugs and does not approve dietary supplements for safety and effectiveness before they reach the market. Companies are responsible for ensuring that dietary-supplement labeling is truthful and appropriately substantiated.
Consumers with diagnosed diabetes, prediabetes or unexplained changes in blood glucose should continue to follow the treatment and monitoring recommendations provided by their healthcare professionals.
Suggested Use and Safety Information
The Olivaro label instructs users to shake well before each use and take one or two droppers full daily, placing the liquid in the mouth and swallowing.
It also states that consumers should not exceed the recommended dose.
Pregnant or nursing individuals, people under 18 and individuals with a known medical condition are directed by the label to consult a physician before using Olivaro or another dietary supplement.
The package also instructs consumers to keep the product out of reach of children and not to use it if the safety seal is damaged or missing.
Storage guidance states that Olivaro should be kept away from heat, light and humidity and stored in a cool, dry location.
Because the formula contains numerous botanical ingredients, consumers who take prescription medicines or multiple dietary supplements should provide their healthcare professional or pharmacist with the complete ingredient list rather than discussing only chromium.
Manufacturing Information
The Olivaro label states that the product is made in the United States with globally sourced ingredients and manufactured in an FDA-registered facility.
FDA registration should not be interpreted as FDA approval of Olivaro, its manufacturing facility or its product claims. FDA states that dietary supplements are not approved for safety and effectiveness before marketing in the way prescription drugs are.
Manufacturing statements therefore describe where and under what regulatory framework a product is produced; they do not constitute clinical evidence.
U.S. Launch and Product Availability
Olivaro has been introduced in the United States as a 30 mL liquid dietary supplement with 30 one-milliliter servings per bottle. A September 28, 2026 public announcement also describes Olivaro as newly launched and confirms the principal Supplement Facts and suggested-use information appearing on the product label.
The launch information focuses on the current formula, liquid serving format, ingredient disclosure and consumer instructions.
The physical package should remain the primary source for current serving directions, Supplement Facts, storage information and warnings because product specifications may change.
About Instituto Experience
Instituto Experience, founded in 2020, focuses on transparency in dietary supplements, aiming to educate consumers about health and wellness while providing high-quality products that meet industry standards.
Olivaro is supplied in a 30 mL dropper bottle and combines 0.7 mcg of chromium per serving with a 200 mg proprietary blend containing botanical extracts, amino acids and related ingredients.
References
-
National Institutes of Health, Office of Dietary Supplements. Chromium — Fact Sheet for Health Professionals.
-
National Center for Complementary and Integrative Health. Diabetes and Dietary Supplements: What You Need to Know.
-
National Center for Complementary and Integrative Health. Green Tea: Usefulness and Safety.
-
National Center for Complementary and Integrative Health. Asian Ginseng: Usefulness and Safety.
-
U.S. Food and Drug Administration. Grapefruit Juice and Some Drugs Don’t Mix.
-
U.S. Food and Drug Administration. FDA 101: Dietary Supplements.
-
Olivaro. Current 2026 U.S. Supplement Facts and Product Label.
Media Contact
Kevin Moore, Product head, Instituto Experience
19655 E 35th Drive, Suite 100, Lakeland, FL 33804
United States
Phone: +1 (507) 448-8190
Email: contact@customercs.com
Consumer Information
Olivaro is a dietary supplement and is not a substitute for medical diagnosis, blood-glucose monitoring or prescribed treatment. Consumers with diabetes, prediabetes or another diagnosed medical condition should continue following guidance from their healthcare professionals.
Research cited in this announcement concerns individual nutrients, botanical ingredients or related dietary-supplement categories and does not constitute clinical evaluation of the complete Olivaro formulation. Differences in dose, extract type, participant population and study design can materially affect whether published findings apply to another product.
These statements have not been evaluated by the U.S. Food and Drug Administration. Olivaro is not intended to diagnose, treat, cure or prevent any disease.
